Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Sagimet Biosciences Inc. (SGMT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Sagimet Biosciences Inc. (SGMT), most recent 12 months reported: net loss $47.08M. Latest balance sheet on file: liquid cash $240.13M. From SEC filings. Others in Pharmaceutical Preparations: Rein Therapeutics, Inc. · Reviva Pharmaceuticals Holdings, Inc. · REVIUM Rx. · Rezolute, Inc. · SHUTTLE PHARMACEUTICALS HOLDINGS, INC. · SIONNA THERAPEUTICS, INC. · Skye Bioscience, Inc. · SELLAS Life Sciences Group, Inc.

Stock screener

Watchlist